Submitted by Anonymous (not verified) on 16 September 2026 - 14:44
Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 20, Status: Authorised
Source: